PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported February 19, 2020

Rompe Pecho EX Expectorant, 6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166. UPC 0 00856 30106 1

Microbial Contamination of Non-Sterile Products

Recall #
D-0846-2020
Affected scope
5387 6 Fl Oz bottles
Initiated
January 31, 2020
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

Efficient Laboratories, Inc. recalled Rompe Pecho EX Expectorant, 6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laborato… - a moderate-severity action.

Rompe Pecho EX Expectorant, 6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laborato… was recalled by Efficient Laboratories, Inc. in February 19, 2020. Reason: Microbial Contamination of Non-Sterile Products. Check the official notice for the remedy. Verify recall #D-0846-2020 with the FDA Drug before acting.

The recall

Efficient Laboratories, Inc. issued this moderate-severity FDA Drug recall-Microbial Contamination of Non-Sterile Products.

Moderate
severity level
Class II
classification
February 19, 2020
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0846-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0846-2020) was formally reported on February 19, 2020, with the manufacturer initiating the action on January 31, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. Efficient Laboratories, Inc. is listed as the recalling firm, operating out of Miami, FL. Federal records list the affected scope as 5387 6 Fl Oz bottles.

The documented reason for this recall is: Microbial Contamination of Non-Sterile Products Distribution data in the federal record shows the product reached: Distributed Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,731 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 146
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

5387 6 Fl Oz bottles

Related Recalls

6

0 from same agency

Product description

Rompe Pecho EX Expectorant, 6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166. UPC 0 00856 30106 1

Reason for recall

Microbial Contamination of Non-Sterile Products

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-0846-2020
Date reported February 19, 2020
Date initiated January 31, 2020
Recalling firm Efficient Laboratories, Inc.
Firm location Miami, FL
Affected scope 5387 6 Fl Oz bottles
Distribution Distributed Nationwide in the USA

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0846-2020) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Rompe Pecho EX Expectorant, 6 FL. Oz (178 mL) bottle, Distributed by: Efficient Laboratories, Inc. Miami, FL 33166. UPC 0 00856 30106 1. Recalled by Efficient Laboratories, Inc.. Units affected: 5387 6 Fl Oz bottles.
Why was this product recalled?
Microbial Contamination of Non-Sterile Products
Which agency issued this recall?
This recall was issued by the FDA Drug on February 19, 2020. Severity: Moderate. Recall number: D-0846-2020.
Where was the recalled product distributed?
Distribution: Distributed Nationwide in the USA.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0846-2020) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →

Browse all Children & Baby Products recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 19, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.